English
Home > Products > CAS NO 1103506-79-1

China CAS NO 1103506-79-1 Factory

Our organization sticks for the principle of "Quality will be the life of your business, and name may be the soul of it" for CAS NO 1103506-79-1,1103506-79-1,Tepotinib intermediate,Tepotinib advance intermediate,3-(1-(3-(5-hydroxypyrimidin-2-yl)benzyl), Leading the trend of this field is our persistent objective. Supplying first class solutions is our intention. To create a beautiful upcoming, we wish to cooperate with all close friends in the home and overseas. Should you have got any interest in our products and solutions, remember to never wait to call us.
CAS NO 1103506-79-1, Taking the core concept of "to be the Responsible". We will redound up on society for high quality solutions and good service. We are going to initiative to participate in international competition to be a first- class manufacturer of this product in the world.

Related Products

Hot Products

  • Titanium dioxide

    Titanium dioxide

    Product Name:Titanium dioxide
    Molecular Formula:O2Ti
    Molecular Weight:79.8658
    CAS Registry Number:13463-67-7
  • Spectinomycin Dihydrochloride

    Spectinomycin Dihydrochloride

    Product Name:Spectinomycin Dihydrochloride
    Molecular Formula:C14H25ClN2O7
    Molecular Weight;368.81
    CAS Registry Number;21736-83-4
  • Sildenafil citrate

    Sildenafil citrate

    Product Name:Sildenafil citrate
    Molecular Formula:C28H38N6O11S
    Molecular Weight;666.7
    CAS Registry Number;171599-83-0
  • RaceAnisodamine

    RaceAnisodamine

    Product Name:RaceAnisodamine
    Molecular Formula:C17H23NO4
    Molecular Weight:305.37
    CAS Registry Number:134355-54-7
  • Ritonavir

    Ritonavir

    Product Name:Ritonavir
    Molecular Formula:C37H48N6O5S2
    Molecular Weight;720.94
    CAS Registry Number;155213-67-5
  • Starch

    Starch

    Product Name:Starch
    Molecular Formula:(C6H10O5)n
    CAS Registry Number:9005-25-8
  • Related Blog
  • Reviews

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • How to find the best China API manufacturer?

    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • Why API manufacturing companies almostly in China?

    In the chemical API industry, developed countries such as the United States and Europe occupy a dominant position in the field of patented APIs with high added value by virtue of their advantages in research and development, production technology, and intellectual property protection...

  • Caffeine CAS No.58-08-2

    Caffeine (CAS No.58-08-2) is a xanthine alkaloid compound, a central nervous stimulant that temporarily drives away drowsiness and restores energy, and is used clinically to treat neurosis and coma recovery. Caffeinated coffee, tea, soft drinks and energy drinks are very popular, so caffeine is also the most commonly used psychotropic drug in the world.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept